VRNA: Verona Pharma plc Company Short-Term Debt

Symbol and logo of brand Verona Pharma (VRNA)

The current size of short-term liabilities confirms Verona Pharma plc (VRNA) resilience to economic downturns, as growth is driven solely by medical breakthroughs. However, reliance on external contractors for production and a compact research staff with stock option programs contribute to volatility. The value of 0.00 captures the metric level, demonstrating the issuer's borrowing dynamics in real time.

VRNA (Verona Pharma PLC) Company Short-Term Debts history from 07/04/2022 to 10/18/2025

Analytical breakdowns and data insights for company Verona Pharma Inc. (VRNA)

- current quotes and average value forecast:
Price Chart Verona Pharma|VRNA - Fair Value Consensus
- market capitalization information:
Market Value Verona Pharma plc|VRNA - Real Price to Acquire Entire Company
- shareholders' equity book value data:
Book Value per Share Verona Pharma|VRNA - Book Capitalization|Market Cap to Net Assets Ratio veronapharma.com|VRNA - Aggregate Asset Value
- debt and liquidity data:
Debt to Equity Verona Pharma plc|VRNA - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio Verona Pharma plc|VRNA - Company Cumulative Indebtedness|Debts to Book Capitalization Verona Pharma plc|VRNA - Company Long-Term Loans and Borrowings|Company Short-Term Debts Verona Pharma|Quick Liquidity veronapharma.com
- net income and valuation multiples indicators:
VRNA - Final Profit
Summary company analytics:Verona Pharma (VRNA)
Mass-produced product of veronapharma.com

Liquidity monitoring is critical for assessing the asset quality of Verona Pharma plc (VRNA). Total short-term debt reflects the volume of credit obligations due within one year. An increase in this indicator signals heightened default risks in the event of an operational cash shortage. For a company at the drug launch stage, such a burden is dangerous due to the uncertainty of future revenues. Minimizing these obligations ensures the financial stability of capital.

Competing companies

HLN - Company Short-Term Debt|Company Short-Term Loans and Borrowings KVUE (Kenvue Inc)|Jyong Biotech Corp (MENS) - Company Short-Term Debt|Company Current Liabilities Ligand Corp|AMRX (Amneal Pharmaceuticals) - Company Short-Term Debts|Company Short-Term Debts perrigo.com|Company Current Liabilities ALVO (Alvotech SA)|LQDA (Liquidia Corp) - Company Short-Term Loans and Borrowings|Company Short-Term Debt Galapagos Genomics GLPG|ANI Pharmaceuticals Corp (ANIP) - Short-Term Debt|MNKD: Company Current Liabilities|amphastar.com - Amount of Current Liabilities|PCRX: Company Short-Term Debts|ARS Pharmaceuticals Inc - Company Short-Term Loans and Borrowings|TBPH (Theravance) - Company Short-Term Debts|Short-Term Debt Aquestive Corp AQST|Company Short-Term Debt scPharmaceuticals Inc. (SCPH)|TECX (tectonictx.com) - Company Short-Term Loans and Borrowings|Tonix Pharmaceuticals Holding Corp. - Company Current Liabilities|SXT Pharmaceuticals - Company Short-Term Debt|Eupraxia Pharma - Company Short-Term Debts|Short-Term Debt BioHarvest Sciences Inc|eXoZymes Inc (EXOZ) - Company Short-Term Debt|Oramed Pharmaceuticals Inc. - Company Short-Term Loans and Borrowings|Company Short-Term Debt Entera Bio Ltd|Short-Term Debt MindWalk Holdings, Inc. HYFT|Company Short-Term Debt ABVC BioPharma Inc (ABVC)|Cumberland Corp - Company Short-Term Indebtedness|Company Short-Term Debts QNTM (Quantum BioPharma Ltd)|Company Short-Term Debts fibrogen.com FGEN|TELO: Company Current Liabilities|Company Short-Term Loans and Borrowings RANI (Rani Therapeutics)|synergychc.com (SNYR) - Company Short-Term Debt|Current Liabilities RLYB (Rallybio)|LEXX (Lexaria Bioscience Corp) - Company Short-Term Debts|PULM: Company Short-Term Loans and Borrowings|Company Short-Term Debts PTHL|Company Short-Term Debts aptorumgroup.com (APM)|Company Short-Term Debt Lyra Therapeutics, Inc LYRA|Company Short-Term Loans and Borrowings IBO|TNFA - Company Short-Term Debt|cbdMD, Inc. (YCBD) - Company Current Liabilities|PRFX: Company Short-Term Debts|Altamira Therapeutics Ltd. (CYTO) - Company Short-Term Debts|Company Current Liabilities LIPO|OPTN: Company Short-Term Loans and Borrowings|Company Short-Term Debt Pieris Pharmaceuticals (PIRS)|PROC: Current Liabilities|Company Short-Term Debt Petros Pharmaceuticals, Inc. PTPI|Qilian International Holding Group - Company Short-Term Debt|ACELYRIN, Inc. - Company Short-Term Debts|TFF Pharmaceuticals, Inc (TFFP) - Company Current Liabilities